{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:12:15Z","timestamp":1794355935235,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Construction Project of High Level Hospital of Jiangsu Province","award":["GSPSJ20240804"],"award-info":[{"award-number":["GSPSJ20240804"]}]},{"name":"Construction Project of High Level Hospital of Jiangsu Province","award":["LCZX202514"],"award-info":[{"award-number":["LCZX202514"]}]},{"name":"Affiliated Hospital of Xuzhou Medical University","award":["2021ZA24"],"award-info":[{"award-number":["2021ZA24"]}]},{"name":"Science and Technology Project of Xuzhou Health Commission","award":["XWKYHT20230062"],"award-info":[{"award-number":["XWKYHT20230062"]}]},{"name":"Jiangsu Provincial Geriatric Health Research Project","award":["LKM2024016"],"award-info":[{"award-number":["LKM2024016"]}]},{"name":"Jiangsu Provincial Health Commission Scientific Research Project","award":["ZQ2024018"],"award-info":[{"award-number":["ZQ2024018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01229-z","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:53:21Z","timestamp":1765198401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Classifying the risk of cognitive impairment in Parkinson\u2019s disease using serum bile acid profiles and machine learning"],"prefix":"10.1038","volume":"12","author":[{"given":"Tong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"1229_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101834","volume":"84","author":"ABR Leite Silva","year":"2023","unstructured":"Leite Silva, A. B. R. et al. Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art. Ageing Res. Rev. 84, 101834 (2023).","journal-title":"Ageing Res. Rev."},{"key":"1229_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1229_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano, C., Barone, P., Trojano, L. & Santangelo, G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: a meta-analysis. Mov. Disord. 35, 45\u201354 (2020).","journal-title":"Mov. Disord."},{"key":"1229_CR4","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops, S. et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738\u20131745 (2009).","journal-title":"Neurology"},{"key":"1229_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.14802\/jmd.16020","volume":"9","author":"JI Kim","year":"2016","unstructured":"Kim, J. I., Sunwoo, M. K., Sohn, Y. H., Lee, P. H. & Hong, J. Y. The MMSE and MoCA for screening cognitive impairment in less educated patients with Parkinson\u2019s disease. J. Mov. Disord. 9, 152\u2013159 (2016).","journal-title":"J. Mov. Disord."},{"key":"1229_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.897867","volume":"13","author":"K Nie","year":"2022","unstructured":"Nie, K. et al. Distinct bile acid signature in parkinson\u2019s disease with mild cognitive impairment. Front. Neurol. 13, 897867 (2022).","journal-title":"Front. Neurol."},{"key":"1229_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40520-024-02729-3","volume":"36","author":"F Nabizadeh","year":"2024","unstructured":"Nabizadeh, F., Valizadeh, P. & Fallahi, M. S. & Alzheimer\u2019s disease Neuroimaging, I. Bile acid profile associated with CSF and PET biomarkers in Alzheimer\u2019s disease. Aging Clin. Exp. Res 36, 62 (2024).","journal-title":"Aging Clin. Exp. Res"},{"key":"1229_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1229_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan, A. H., Lim, S. Y. & Lang, A. E. The microbiome-gut-brain axis in Parkinson disease\u2014from basic research to the clinic. Nat. Rev. Neurol. 18, 476\u2013495 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"1229_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang, X., Tang, B. & Guo, J. Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies. Transl. Neurodegener. 12, 59 (2023).","journal-title":"Transl. Neurodegener."},{"key":"1229_CR11","doi-asserted-by":"publisher","unstructured":"Li, P. et al. Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson\u2019s disease. Metabolites 11, https:\/\/doi.org\/10.3390\/metabo11010029 (2021).","DOI":"10.3390\/metabo11010029"},{"key":"1229_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41575-024-00896-2","volume":"21","author":"JM Ridlon","year":"2024","unstructured":"Ridlon, J. M. & Gaskins, H. R. Another renaissance for bile acid gastrointestinal microbiology. Nat. Rev. Gastroenterol. Hepatol. 21, 348\u2013364 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1229_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101210","volume":"89","author":"S Lin","year":"2023","unstructured":"Lin, S. et al. Bile acids and their receptors in regulation of gut health and diseases. Prog. Lipid Res. 89, 101210 (2023).","journal-title":"Prog. Lipid Res."},{"key":"1229_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.dld.2014.01.159","volume":"46","author":"M Quinn","year":"2014","unstructured":"Quinn, M. et al. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Dig. Liver Dis. 46, 527\u2013534 (2014).","journal-title":"Dig. Liver Dis."},{"key":"1229_CR15","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1096\/fj.201600275R","volume":"30","author":"M McMillin","year":"2016","unstructured":"McMillin, M. & DeMorrow, S. Effects of bile acids on neurological function and disease. FASEB J. 30, 3658\u20133668 (2016).","journal-title":"FASEB J."},{"key":"1229_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-021-00398-4","volume":"3","author":"A Perino","year":"2021","unstructured":"Perino, A. et al. Central anorexigenic actions of bile acids are mediated by TGR5. Nat. Metab. 3, 595\u2013603 (2021).","journal-title":"Nat. Metab."},{"key":"1229_CR17","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","volume":"33","author":"A Castellanos-Jankiewicz","year":"2021","unstructured":"Castellanos-Jankiewicz, A. et al. Hypothalamic bile acid-TGR5 signaling protects from obesity. Cell Metab. 33, 1483\u20131492 e1410 (2021).","journal-title":"Cell Metab."},{"key":"1229_CR18","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1021\/acs.jproteome.8b00224","volume":"17","author":"SF Graham","year":"2018","unstructured":"Graham, S. F. et al. Biochemical profiling of the brain and blood metabolome in a mouse model of prodromal Parkinson\u2019s disease reveals distinct metabolic profiles. J. Proteome Res. 17, 2460\u20132469 (2018).","journal-title":"J. Proteome Res."},{"key":"1229_CR19","doi-asserted-by":"publisher","unstructured":"Graham, S. F. et al. Metabolomic profiling of bile acids in an experimental model of prodromal Parkinson\u2019s disease. Metabolites 8, https:\/\/doi.org\/10.3390\/metabo8040071 (2018).","DOI":"10.3390\/metabo8040071"},{"key":"1229_CR20","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/mds.29450","volume":"38","author":"T Payne","year":"2023","unstructured":"Payne, T. et al. A double-blind, randomized, placebo-controlled trial of ursodeoxycholic acid (UDCA) in Parkinson\u2019s disease. Mov. Disord. 38, 1493\u20131502 (2023).","journal-title":"Mov. Disord."},{"key":"1229_CR21","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.bbadis.2017.06.004","volume":"1863","author":"AI Rosa","year":"2017","unstructured":"Rosa, A. I. et al. Novel insights into the antioxidant role of tauroursodeoxycholic acid in experimental models of Parkinson\u2019s disease. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 2171\u20132181 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1229_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-022-00307-z","volume":"11","author":"K Khalaf","year":"2022","unstructured":"Khalaf, K., Tornese, P., Cocco, A. & Albanese, A. Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases. Transl. Neurodegener. 11, 33 (2022).","journal-title":"Transl. Neurodegener."},{"key":"1229_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70076","volume":"4","author":"Z Zhao","year":"2025","unstructured":"Zhao, Z. et al. Multi-omics identifies microbiota-derived deoxycholic acid as a key mediator of blood-brain barrier dysfunction in Parkinson\u2019s disease. Imeta. 4, e70076 (2025).","journal-title":"Imeta."},{"key":"1229_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado1855","volume":"10","author":"C Li","year":"2024","unstructured":"Li, C. et al. TGR5 deficiency in excitatory neurons ameliorates Alzheimer\u2019s pathology by regulating APP processing. Sci. Adv. 10, eado1855 (2024).","journal-title":"Sci. Adv."},{"key":"1229_CR25","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.cell.2024.02.019","volume":"187","author":"I Mohanty","year":"2024","unstructured":"Mohanty, I. et al. The underappreciated diversity of bile acid modifications. Cell 187, 1801\u20131818 e1820 (2024).","journal-title":"Cell"},{"key":"1229_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman, J. S. & Kumar, S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9, 97 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1229_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13578-023-01053-z","volume":"13","author":"C Xing","year":"2023","unstructured":"Xing, C. et al. Roles of bile acids signaling in neuromodulation under physiological and pathological conditions. Cell Biosci. 13, 106 (2023).","journal-title":"Cell Biosci."},{"key":"1229_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641 e627 (2019).","journal-title":"Neuron"},{"key":"1229_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","volume":"16","author":"Y Shao","year":"2021","unstructured":"Shao, Y. et al. Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry. Mol. Neurodegener. 16, 4 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1229_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","volume":"44","author":"A Bertolini","year":"2022","unstructured":"Bertolini, A., Fiorotto, R. & Strazzabosco, M. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation. Semin Immunopathol. 44, 547\u2013564 (2022).","journal-title":"Semin Immunopathol."},{"key":"1229_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/ADR-220071","volume":"7","author":"T Ehtezazi","year":"2023","unstructured":"Ehtezazi, T., Rahman, K., Davies, R. & Leach, A. G. The pathological effects of circulating hydrophobic bile acids in Alzheimer\u2019s disease. J. Alzheimers Dis. Rep. 7, 173\u2013211 (2023).","journal-title":"J. Alzheimers Dis. Rep."},{"key":"1229_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41531-024-00724-z","volume":"10","author":"H Nishiwaki","year":"2024","unstructured":"Nishiwaki, H. et al. Meta-analysis of shotgun sequencing of gut microbiota in Parkinson\u2019s disease. NPJ Parkinsons Dis. 10, 106 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"1229_CR33","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.3748\/wjg.v29.i22.3400","volume":"29","author":"I Efremova","year":"2023","unstructured":"Efremova, I. et al. Epidemiology of small intestinal bacterial overgrowth. World J. Gastroenterol. 29, 3400\u20133421 (2023).","journal-title":"World J. Gastroenterol."},{"key":"1229_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1053\/j.gastro.2022.05.005","volume":"163","author":"S Balesaria","year":"2022","unstructured":"Balesaria, S. et al. Common genetic variants in the bile acid synthesis enzyme CYP7A1 are associated with severe primary bile acid diarrhea. Gastroenterology 163, 517\u2013519 e512 (2022).","journal-title":"Gastroenterology"},{"key":"1229_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila, A. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat. Commun. 11, 362 (2020).","journal-title":"Nat. Commun."},{"key":"1229_CR36","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois, B. et al. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov. Disord. 22, 2314\u20132324 (2007).","journal-title":"Mov. Disord."},{"key":"1229_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.parkreldis.2014.08.002","volume":"20","author":"N Kandiah","year":"2014","unstructured":"Kandiah, N. et al. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson\u2019s disease. Park. Relat. Disord. 20, 1145\u20131148 (2014).","journal-title":"Park. Relat. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01229-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01229-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01229-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:06:56Z","timestamp":1768367216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01229-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01229-z","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Language editing assistance was provided using ChatGPT4O (OpenAI, San Francisco, USA) to improve the clarity, consistency, and grammar of the manuscript. This tool was used solely for linguistic refinement and abbreviation standardization; no scientific content, data interpretation, or conclusions were modified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}],"article-number":"18"}}